Activation-induced tumor necrosis factor receptorassociated factor 3 (Traf3) alternative splicing controls the noncanonical nuclear factor κB pathway and chemokine expression in human T cells

Journal of Biological Chemistry

Volumn 289, Issue 19, 2014, Pages 13651-13660

  Michel, Monika ^a,b   Wilhelmi, Ilka ^a,b   Schultz, Astrid Solveig ^a,b   Preussner, Marco ^a,b   Heyd, Florian ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOASSAY; CELL CULTURE; CELLS; PEPTIDES;

ACTIVITY RESULTS; ADAPTIVE IMMUNITY; ALTERNATIVE SPLICING; CHEMOATTRACTANTS; CHEMOKINE EXPRESSION; COMPLEX TARGETS; FULL-LENGTH PROTEINS; TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED FACTORS;

CELL SIGNALING;

CXCL13 CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3;

ADAPTIVE IMMUNITY; ALTERNATIVE RNA SPLICING; ARTICLE; B LYMPHOCYTE; BIOACCUMULATION; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; EXON; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ALTERNATIVE SPLICING; NUCLEAR FACTOR ΚB (NFΚB); RNA SPLICING; T CELL; TRAF;

ADAPTIVE IMMUNITY; ALTERNATIVE SPLICING; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINE CXCL13; HELA CELLS; HUMANS; NF-KAPPA B; PROTEIN ISOFORMS; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 2; TNF RECEPTOR-ASSOCIATED FACTOR 3;

EID: 84900422452     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.526269     Document Type: Article

References (40)

1. Black, D. L. (2003) Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem. 72, 291-336
2. Barbosa-Morais, N. L., Irimia, M., Pan, Q., Xiong, H. Y., Gueroussov, S., Lee, L. J., Slobodeniuc, V., Kutter, C, Watt, S., Colak, R., Kim, T., Misquitta-Ali, C. M., Wilson, M. D., Kim, P. M., Odom, D. T., Frey, B. J., and Blencowe, B. J. (2012) The evolutionary landscape of alternative splicing in vertebrate species. Science 338, 1587-1593
3. Martinez, N. M., Pan, Q., Cole, B. S., Yarosh, C. A., Babcock, G. A., Heyd, F., Zhu, W., Ajith, S., Blencowe, B. J., and Lynch, K. W. (2012) Alternative splicing networks regulated by signaling in human T cells. RNA 18, 1029-1040
4. Merkin, J., Russell, C., Chen, P., and Burge, C. B. (2012) Evolutionary dynamics of gene and isoform regulation in mammalian tissues. Science 338, 1593-1599
5. Martinez, N. M., and Lynch, K. W. (2013) Control of alternative splicing in immune responses: many regulators, many predictions, much still to learn. Immunol. Rev. 253, 216-236
6. Smith-Garvin, J. E., Koretzky, G. A., and Jordan, M. S. (2009) T cell activation. Annu. Rev. Immunol. 27, 591-619
7. David, C. J., Chen, M., Assanah, M., Canoll, P., and Manley, J. L. (2010) HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature 463, 364-368
8. Gabut, M., Samavarchi-Tehrani, P., Wang, X., Slobodeniuc, V., O'Hanlon, D., Sung, H. K., Alvarez, M., Talukder, S., Pan, Q., Mazzoni, E. O., Nedelec, S., Wichterle, H., Woltjen, K., Hughes, T. R., Zandstra, P. W., Nagy, A., Wrana, J. L., and Blencowe, B. J. (2011) An alternative splicing switch regulates embryonic stem cell pluripotency and reprogramming. Cell 147, 132-146
9. Warzecha, C. C, Jiang, P., Amirikian, K., Dittmar, K. A., Lu, H., Shen, S., Guo, W., Xing, Y., and Carstens, R. P. (2010) An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transition. EMBOJ. 29, 3286-3300
10. Xu, X., Yang, D., Ding, J. H., Wang, W., Chu, P. H., Dalton, N. D., Wang, H. Y., Bermingham, J. R., Jr., Ye, Z., Liu, F., Rosenfeld, M. G., Manley, J. L., Ross, J., Jr., Chen, J., Xiao, R. P., Cheng, H., and Fu, X. D. (2005) ASF/SF2-regulated CaMKIIΔ alternative splicing temporally reprograms excitation-contraction coupling in cardiac muscle. Cell 120, 59-72
11. Buljan, M., Chalancon, G., Eustermann, S., Wagner, G. P., Fuxreiter, M., Bateman, A., and Babu, M. M. (2012) Tissue-specific splicing of disordered segments that embed binding motifs rewires protein interaction networks. Mol. Cell 46, 871-883
12. Ellis, J. D., Barrios-Rodiles, M., Colak, R., Irimia, M., Kim, T., Calarco, J. A., Wang, X., Pan, Q., O'Hanlon, D., Kim, P. M., Wrana, J. L., and Blencowe, B. J. (2012) Tissue-specific alternative splicing remodels protein-protein interaction networks. Mol. Cell 46, 884-892
13. Razani, B., Reichardt, A. D., and Cheng, G. (2011) Noncanonical NF-κB signaling activation and regulation: principles and perspectives. Immunol. Rev. 244, 44-54
14. Bonizzi, G., Bebien, M., Otero, D. C, Johnson-Vroom, K. E., Cao, Y., Vu, D., Jegga, A. G., Aronow, B. J., Ghosh, G., Rickert, R. C., and Karin, M. (2004) Activation of IKKα target genes depends on recognition of specific kB binding sites by RelB: p52 dimers. EMBO J. 23, 4202-4210
15. Bonizzi, G., and Karin, M. (2004) The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25, 280-288
16. Ansel, K. M., Ngo, V. N., Hyman, P. L., Luther, S. A., Förster, R., Sedgwick, J. D., Browning, J. L., Lipp, M., and Cyster, J. G. (2000) Achemokine-driven positive feedback loop organizes lymphoid follicles. Nature 406, 309-314
17. Sun, S. C. (2012) The noncanonical NF-κB pathway. Immunol. Rev. 246, 125-140
18. Allen, C. D., Ansel, K. M., Low, C., Lesley, R., Tamamura, H., Fujii, N., and Cyster, J. G. (2004) Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nat. Immunol. 5, 943-952
19. Kim, C. H., Lim, H. W., Kim, J. R., Rott, L., Hillsamer, P., and Butcher, E. C. (2004) Unique gene expression program of human germinal center T helper cells. Blood 104, 1952-1960
20. Manzo, A., Vitolo, B., Humby, F., Caporali, R., Jarrossay, D., Dell'accio, F., Ciardelli, L., Uguccioni, M., Montecucco, C., and Pitzalis, C. (2008) Mature antigen-experienced T helper cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of the rheumatoid joint. Arthritis Rheum. 58, 3377-3387
21. He, J. Q., Saha, S. K., Kang, J. R., Zarnegar, B., and Cheng, G. (2007) Specificity of TRAF3 in its negative regulation of the noncanonical NF-κB pathway. J. Biol. Chem. 282, 3688-3694
22. Liao, G., Zhang, M., Harhaj, E. W., and Sun, S. C. (2004) Regulation of the NF-κB-inducing kinase by tumor necrosis factor receptor-Associated factor 3-induced degradation. J. Biol. Chem. 279, 26243-26250
23. Matsushima, A., Kaisho, T., Rennert, P. D., Nakano, H., Kurosawa, K., Uchida, D., Takeda, K., Akira, S., and Matsumoto, M. (2001) Essential role of nuclear factor (NF) -κB-inducing kinase and inhibitor of κB (IκB) kinase α in NF-κB activation through lymphotoxin β receptor, but not through tumor necrosis factor receptor I. J. Exp. Med. 193, 631-636
24. Vallabhapurapu, S., Matsuzawa, A., Zhang, W., Tseng, P. H., Keats, J. J., Wang, H., Vignali, D. A., Bergsagel, P. L., and Karin, M. (2008) Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling. Nat. Immunol. 9, 1364-1370
25. Zarnegar, B. J., Wang, Y., Mahoney, D. J., Dempsey, P. W., Cheung, H. H., He, J., Shiba, T., Yang, X., Yeh, W. C, Mak, T. W., Korneluk, R. G., and Cheng, G. (2008) Noncanonical NF-κB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2, and TRAF3 and the kinase NIK. Nat. Immunol. 9, 1371-1378
26. McPherson, A. J., Snell, L. M., Mak, T. W., and Watts, T. H. (2012) Opposing roles for TRAF1 in the alternative versus classical NF-κB pathway in T cells. J. Biol. Chem. 287, 23010-23019
27. Hu, H, Brittain, G. C, Chang, J. H., Puebla-Osorio, N., Jin, J., Zal, A., Xiao, Y., Cheng, X., Chang, M., Fu, Y. X., Zal, T., Zhu, C, and Sun, S. C. (2013) OTUD7B controls noncanonical NF-kB activation through deubiquitination of TRAF3. Nature 494, 371-374
28. Xie, P., Kraus, Z. J., Stunz, L. L., Liu, Y., and Bishop, G. A. (2011) TNF receptor-Associated factor 3 is required for T cell-mediated immunity and TCR/CD28 signaling. J. Immunol. 186, 143-155
29. van Eyndhoven, W. G., Gamper, C. J., Cho, E., Mackus, W. J., and Lederman, S. (1999) TRAF-3 mRNA splice-deletion variants encode isoforms that induce NF-κB activation. Mol. Immunol. 36, 647-658
30. Heyd, F., and Lynch, K. W. (2010) Phosphorylation-dependent regulation of PSFby GSK3 controls CD45 alternative splicing. Mol. Cell 40, 126-137
31. Lynch, K. W., and Weiss, A. (2000) A model system for activation-induced alternative splicing of CD45 pre-mRNA in T cells implicates protein kinase C and Ras. Mol. Cell. Biol. 20, 70-80
32. Heyd, F., and Lynch, K. W. (2011) PSF controls expression of histone variants and cellular viability in thymocytes. Biochem. Biophys. Res. Commun. 414, 743-749
33. Ishimaru, N., Kishimoto, H, Hayashi, Y., and Sprent, J. (2006) Regulation of naive T cell function by the NF-κB2 pathway. Nat. Immunol. 7, 763-772
34. Hu, H., Wu, X., Jin, W., Chang, M., Cheng, X., and Sun, S. C. (2011) Noncanonical NF-κB regulates inducible costimulator (ICOS) ligand expression and T follicular helper cell development. Proc. Natl. Acad. Sci. U. S. A. 108, 12827-12832
35. Häcker, H, Tseng, P. H, and Karin, M. (2011) Expanding TRAF function: TRAF3 as a tri-faced immune regulator. Nat. Rev. Immunol. 11, 457-468
36. He, L., Grammer, A. C, Wu, X., and Lipsky, P. E. (2004) TRAF3 forms heterotrimers with TRAF2 and modulates its ability to mediate NF-kB activation. J. Biol. Chem. 279, 55855-55865
37. Sáez de Guinoa, J., Barrio, L., Mellado, M., and Carrasco, Y. R. (2011) CXCL13/CXCR5 signaling enhances BCR-triggered B-cell activation by shaping cell dynamics. Blood 118, 1560-1569
38. Heyd, F., and Lynch, K. W. (2009) Getting under the skin of alternative splicing: identification of epithelial-specific splicing factors. Mol. Cell 33, 674-676
39. Topp, J. D., Jackson, J., Melton, A. A., and Lynch, K. W. (2008) A cell-based screen for splicing regulators identifies hnRNP LL as a distinct signalinduced repressor of CD45 variable exon 4. RNA 14, 2038-2049
40. Warzecha, C. C, and Carstens, R. P. (2012) Complex changes in alternative pre-mRNA splicing play a central role in the epithelial-to-mesenchymal transition (EMT). Semin. Cancer Biol. 22, 417-427